

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.28587869 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.28587869 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.27397469 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.27397469 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.27397469 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.27397469 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.27397469 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.27397469 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10602813 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10602813 |
| 11 | leukocyte aggregation (GO:0070486) | 5.08470097 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.95557647 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.92775130 |
| 14 | detection of other organism (GO:0098543) | 4.92195188 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.81234132 |
| 16 | detection of bacterium (GO:0016045) | 4.78218193 |
| 17 | cellular extravasation (GO:0045123) | 4.31332755 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.27453450 |
| 19 | respiratory burst (GO:0045730) | 4.18303590 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.14297355 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.10280005 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.08092233 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.06365276 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.02837050 |
| 25 | response to peptidoglycan (GO:0032494) | 3.90215731 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.87010357 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.82829814 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.80239513 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77978083 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.73289736 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.69479439 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68313068 |
| 33 | tolerance induction (GO:0002507) | 3.64144373 |
| 34 | leukocyte cell-cell adhesion (GO:0007159) | 3.63460543 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.62141245 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.62096972 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.53164670 |
| 38 | response to host immune response (GO:0052572) | 3.52902703 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52902703 |
| 40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50903634 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.49731089 |
| 42 | T cell migration (GO:0072678) | 3.49543787 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.49273075 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.48647914 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.48172569 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.46228712 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.43365891 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.41845658 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.39396326 |
| 50 | response to host (GO:0075136) | 3.39378650 |
| 51 | response to host defenses (GO:0052200) | 3.39378650 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39378650 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37538354 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.37014248 |
| 55 | negative T cell selection (GO:0043383) | 3.33214514 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.32818804 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.31469730 |
| 58 | neutrophil activation (GO:0042119) | 3.31356497 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.28707348 |
| 60 | granulocyte activation (GO:0036230) | 3.28523877 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28346024 |
| 62 | microglial cell activation (GO:0001774) | 3.28242910 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27426454 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24851028 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.20939830 |
| 66 | macrophage activation (GO:0042116) | 3.19150521 |
| 67 | thymic T cell selection (GO:0045061) | 3.15798956 |
| 68 | actin nucleation (GO:0045010) | 3.14937663 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.11797664 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.09150710 |
| 71 | positive regulation of mast cell degranulation (GO:0043306) | 3.08453259 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08453259 |
| 73 | neutrophil mediated immunity (GO:0002446) | 3.04810774 |
| 74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.03788510 |
| 75 | activated T cell proliferation (GO:0050798) | 3.03481575 |
| 76 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02517208 |
| 77 | positive regulation of lamellipodium assembly (GO:0010592) | 3.00854663 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00516343 |
| 79 | leukocyte degranulation (GO:0043299) | 2.98578756 |
| 80 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.97327208 |
| 81 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.97327208 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97267628 |
| 83 | cellular response to interleukin-15 (GO:0071350) | 2.97247832 |
| 84 | B cell mediated immunity (GO:0019724) | 2.96506725 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96435187 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.92739441 |
| 87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92069347 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 2.90499021 |
| 89 | mannose metabolic process (GO:0006013) | 2.89892750 |
| 90 | myeloid dendritic cell differentiation (GO:0043011) | 2.88407487 |
| 91 | positive T cell selection (GO:0043368) | 2.87920264 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85829627 |
| 93 | neutrophil chemotaxis (GO:0030593) | 2.85327356 |
| 94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.84977962 |
| 95 | response to laminar fluid shear stress (GO:0034616) | 2.83500358 |
| 96 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83429761 |
| 97 | barbed-end actin filament capping (GO:0051016) | 2.83336046 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83325655 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.82036309 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.81811745 |
| 101 | T cell selection (GO:0045058) | 2.81609407 |
| 102 | pinocytosis (GO:0006907) | 2.81122686 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80907089 |
| 104 | neutrophil migration (GO:1990266) | 2.79622030 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77250314 |
| 106 | positive regulation of isotype switching (GO:0045830) | 2.76121205 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 2.75266656 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74812991 |
| 109 | negative regulation of type 2 immune response (GO:0002829) | 2.74621757 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74616130 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74436321 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.74154437 |
| 113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73935039 |
| 114 | germinal center formation (GO:0002467) | 2.73104586 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.71919943 |
| 116 | response to interleukin-15 (GO:0070672) | 2.71412926 |
| 117 | apoptotic cell clearance (GO:0043277) | 2.71253404 |
| 118 | interferon-gamma production (GO:0032609) | 2.69554696 |
| 119 | positive regulation of lamellipodium organization (GO:1902745) | 2.69543424 |
| 120 | regulation of mast cell degranulation (GO:0043304) | 2.69319227 |
| 121 | response to protozoan (GO:0001562) | 2.67419993 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66786351 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.66673090 |
| 124 | defense response to protozoan (GO:0042832) | 2.66513495 |
| 125 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65775670 |
| 126 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64100118 |
| 127 | response to type I interferon (GO:0034340) | 2.63260133 |
| 128 | sequestering of actin monomers (GO:0042989) | 2.62718349 |
| 129 | regulation of leukocyte degranulation (GO:0043300) | 2.60786850 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.60452552 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.60452552 |
| 132 | regulation of mast cell activation (GO:0033003) | 2.59290718 |
| 133 | T cell costimulation (GO:0031295) | 2.58187897 |
| 134 | T cell proliferation (GO:0042098) | 2.57107469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.01309868 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84956823 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.70666604 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65565443 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.45992611 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45065203 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33805538 |
| 8 | * MYC_22102868_ChIP-Seq_BL_Human | 3.23058649 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10827174 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.05935111 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.04144819 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.01033111 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87885452 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.78324328 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64478478 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.62465689 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59267969 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.52916292 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.49010524 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40920432 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.39730552 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.31318714 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27843033 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.25217911 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23737936 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20909780 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18843100 |
| 28 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14586369 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11489341 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.10067283 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08803941 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05190265 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01174543 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97493651 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96525535 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95598295 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.91998451 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91573630 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90392663 |
| 40 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90155658 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87727775 |
| 42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86693404 |
| 43 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80259676 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79771761 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79252746 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68530212 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.64258701 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64217060 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59591481 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58861541 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57902701 |
| 52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54579258 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54103755 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50775288 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50328408 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49230490 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46722299 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43902740 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42576587 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42525632 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40176804 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36628443 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36415476 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34987183 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33676301 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32434945 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24883141 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21189959 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20784349 |
| 70 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15183508 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15125048 |
| 72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14340880 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13149931 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12116239 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10808111 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10109799 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09862992 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09550605 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04902119 |
| 80 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03070193 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02453532 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01887743 |
| 83 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01655168 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01485884 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98631020 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98069435 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96307674 |
| 88 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94725313 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94250559 |
| 90 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93869029 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93609654 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92548536 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92442336 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91950353 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91647170 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89234221 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88206911 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87193963 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87121294 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86386649 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86156874 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85932257 |
| 103 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.84691688 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84672020 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83048951 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82955106 |
| 107 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82713971 |
| 108 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81380202 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80499768 |
| 110 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.80351067 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78780917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.29512537 |
| 2 | MP0003436_decreased_susceptibility_to | 3.71327130 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.62254233 |
| 4 | MP0000685_abnormal_immune_system | 3.03319870 |
| 5 | MP0005387_immune_system_phenotype | 3.00037461 |
| 6 | MP0001790_abnormal_immune_system | 3.00037461 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.90350547 |
| 8 | MP0002419_abnormal_innate_immunity | 2.80072254 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.79158400 |
| 10 | MP0001800_abnormal_humoral_immune | 2.78270362 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.75525409 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.69346857 |
| 13 | MP0005025_abnormal_response_to | 2.61918057 |
| 14 | MP0009785_altered_susceptibility_to | 2.59510715 |
| 15 | MP0006082_CNS_inflammation | 2.51157485 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.47703445 |
| 17 | MP0001819_abnormal_immune_cell | 2.46207879 |
| 18 | MP0002723_abnormal_immune_serum | 2.43757967 |
| 19 | MP0005671_abnormal_response_to | 2.41461551 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.38678687 |
| 21 | MP0004510_myositis | 2.34541591 |
| 22 | MP0002405_respiratory_system_inflammati | 2.28778420 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.22363947 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.13672689 |
| 25 | MP0009278_abnormal_bone_marrow | 2.08101725 |
| 26 | MP0002398_abnormal_bone_marrow | 2.06999518 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.06357127 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.04674467 |
| 29 | MP0008260_abnormal_autophagy | 2.00907817 |
| 30 | MP0000716_abnormal_immune_system | 1.96901882 |
| 31 | MP0004947_skin_inflammation | 1.95733644 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.94619197 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.83230683 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.80801825 |
| 35 | MP0003724_increased_susceptibility_to | 1.79377911 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.76617175 |
| 37 | MP0001873_stomach_inflammation | 1.75433342 |
| 38 | MP0009840_abnormal_foam_cell | 1.71890243 |
| 39 | MP0002722_abnormal_immune_system | 1.71165597 |
| 40 | MP0002429_abnormal_blood_cell | 1.65465718 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.64117620 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.61835086 |
| 43 | MP0001853_heart_inflammation | 1.61325131 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.60610656 |
| 45 | MP0005451_abnormal_body_composition | 1.59108846 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.58112990 |
| 47 | MP0003448_altered_tumor_morphology | 1.55983277 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.52273736 |
| 49 | MP0000858_altered_metastatic_potential | 1.50362387 |
| 50 | MP0002933_joint_inflammation | 1.44941832 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.44508544 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.43386735 |
| 53 | MP0002132_abnormal_respiratory_system | 1.40724203 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.40149840 |
| 55 | MP0005310_abnormal_salivary_gland | 1.39730423 |
| 56 | MP0001851_eye_inflammation | 1.35525062 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.34691989 |
| 58 | MP0000490_abnormal_crypts_of | 1.34531958 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.34114095 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.34114095 |
| 61 | MP0008469_abnormal_protein_level | 1.31151228 |
| 62 | MP0003866_abnormal_defecation | 1.26882171 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.26601412 |
| 64 | MP0003075_altered_response_to | 1.26585900 |
| 65 | MP0002006_tumorigenesis | 1.26214682 |
| 66 | MP0000343_altered_response_to | 1.26182933 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.24849924 |
| 68 | MP0004883_abnormal_blood_vessel | 1.24644099 |
| 69 | MP0010307_abnormal_tumor_latency | 1.16037437 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.13638381 |
| 71 | MP0000604_amyloidosis | 1.11856406 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.06615590 |
| 73 | MP0005164_abnormal_response_to | 1.05000456 |
| 74 | MP0005166_decreased_susceptibility_to | 1.04091386 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.00322045 |
| 76 | MP0005023_abnormal_wound_healing | 0.97247291 |
| 77 | MP0004858_abnormal_nervous_system | 0.97050009 |
| 78 | MP0005390_skeleton_phenotype | 0.90849598 |
| 79 | MP0001663_abnormal_digestive_system | 0.89061641 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.88121529 |
| 81 | MP0009764_decreased_sensitivity_to | 0.86087263 |
| 82 | MP0008004_abnormal_stomach_pH | 0.86015578 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.85197721 |
| 84 | MP0004381_abnormal_hair_follicle | 0.82530992 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.80153513 |
| 86 | MP0003091_abnormal_cell_migration | 0.79152874 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.77631682 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.77223578 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.76421962 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.75123791 |
| 91 | MP0000249_abnormal_blood_vessel | 0.74841415 |
| 92 | MP0003795_abnormal_bone_structure | 0.74226413 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.72087819 |
| 94 | MP0001849_ear_inflammation | 0.70275674 |
| 95 | MP0003828_pulmonary_edema | 0.70254252 |
| 96 | MP0009763_increased_sensitivity_to | 0.67758077 |
| 97 | MP0003690_abnormal_glial_cell | 0.65281764 |
| 98 | MP0001915_intracranial_hemorrhage | 0.64641187 |
| 99 | MP0008874_decreased_physiological_sensi | 0.63582818 |
| 100 | MP0000371_diluted_coat_color | 0.62695426 |
| 101 | MP0001542_abnormal_bone_strength | 0.62429231 |
| 102 | MP0001958_emphysema | 0.61945662 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.60712370 |
| 104 | MP0003279_aneurysm | 0.57013440 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.56755524 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.56654790 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.56597705 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.55808629 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.54685667 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54024756 |
| 111 | MP0002135_abnormal_kidney_morphology | 0.52526791 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.50989028 |
| 113 | MP0008873_increased_physiological_sensi | 0.50816200 |
| 114 | MP0000733_abnormal_muscle_development | 0.50293550 |
| 115 | MP0003045_fibrosis | 0.49582114 |
| 116 | MP0000609_abnormal_liver_physiology | 0.48742346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.30488155 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.06263697 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.15018921 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.83800219 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.31693467 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.10590787 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.09498745 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.85795196 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.83813737 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82111851 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.77541374 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.72740979 |
| 13 | Obstructive lung disease (HP:0006536) | 3.70701398 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70701398 |
| 15 | Myositis (HP:0100614) | 3.64393245 |
| 16 | IgM deficiency (HP:0002850) | 3.50043065 |
| 17 | Pustule (HP:0200039) | 3.45219899 |
| 18 | Cellulitis (HP:0100658) | 3.44150363 |
| 19 | Gingivitis (HP:0000230) | 3.36864183 |
| 20 | Recurrent skin infections (HP:0001581) | 3.33522953 |
| 21 | Encephalitis (HP:0002383) | 3.29489853 |
| 22 | Recurrent viral infections (HP:0004429) | 3.26402053 |
| 23 | Nasal polyposis (HP:0100582) | 3.23271496 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.12948687 |
| 25 | Stomatitis (HP:0010280) | 3.12531079 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10294397 |
| 27 | Chronic otitis media (HP:0000389) | 3.10128413 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.09403818 |
| 29 | Mucopolysacchariduria (HP:0008155) | 3.08566747 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08566747 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 2.99715940 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 2.94495862 |
| 33 | Meningitis (HP:0001287) | 2.92510601 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86844248 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86844248 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86844248 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.86765278 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.85833526 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84511636 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.82854975 |
| 41 | Orchitis (HP:0100796) | 2.80840276 |
| 42 | Disinhibition (HP:0000734) | 2.80422810 |
| 43 | Increased density of long bones (HP:0006392) | 2.79930469 |
| 44 | Amyloidosis (HP:0011034) | 2.78763607 |
| 45 | Glomerulonephritis (HP:0000099) | 2.77892387 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76421895 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76421895 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76421895 |
| 49 | Vasculitis (HP:0002633) | 2.72373652 |
| 50 | Peritonitis (HP:0002586) | 2.70957866 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.66070519 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.66070519 |
| 53 | Episodic fever (HP:0001954) | 2.65596214 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.64676626 |
| 55 | Increased IgM level (HP:0003496) | 2.62351471 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.58461272 |
| 57 | Urticaria (HP:0001025) | 2.58292339 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58076279 |
| 59 | Loss of speech (HP:0002371) | 2.52424201 |
| 60 | Periodontitis (HP:0000704) | 2.51851418 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.51269015 |
| 62 | Colitis (HP:0002583) | 2.51128220 |
| 63 | Purpura (HP:0000979) | 2.48192768 |
| 64 | Petechiae (HP:0000967) | 2.45675627 |
| 65 | T lymphocytopenia (HP:0005403) | 2.45585140 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.41898720 |
| 67 | Abnormality of T cells (HP:0002843) | 2.41015153 |
| 68 | Verrucae (HP:0200043) | 2.33301425 |
| 69 | Papilloma (HP:0012740) | 2.33301425 |
| 70 | Leukocytosis (HP:0001974) | 2.31001711 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.30687670 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.26357459 |
| 73 | Osteomyelitis (HP:0002754) | 2.25106955 |
| 74 | Hematochezia (HP:0002573) | 2.24803462 |
| 75 | Chest pain (HP:0100749) | 2.24310615 |
| 76 | Increased IgE level (HP:0003212) | 2.24275136 |
| 77 | Optic neuritis (HP:0100653) | 2.23518206 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.23518206 |
| 79 | Anorexia (HP:0002039) | 2.23027674 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.22820927 |
| 81 | Granulocytopenia (HP:0001913) | 2.22067588 |
| 82 | Lymphopenia (HP:0001888) | 2.21197940 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19862799 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.19784628 |
| 85 | Glomerulopathy (HP:0100820) | 2.18771375 |
| 86 | Arterial thrombosis (HP:0004420) | 2.18315679 |
| 87 | Abnormality of the peritoneum (HP:0002585) | 2.15315508 |
| 88 | Pulmonary embolism (HP:0002204) | 2.14799642 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.13577959 |
| 90 | Hypochromic anemia (HP:0001931) | 2.13166853 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.12956495 |
| 92 | Thrombocytosis (HP:0001894) | 2.12912107 |
| 93 | Spondylolisthesis (HP:0003302) | 2.12451721 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.06994032 |
| 95 | Increased serum ferritin (HP:0003281) | 2.06802572 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.05313926 |
| 97 | Skin ulcer (HP:0200042) | 2.03086632 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.01663252 |
| 99 | Hypertensive crisis (HP:0100735) | 2.00016661 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.99670231 |
| 101 | Hemoptysis (HP:0002105) | 1.99599387 |
| 102 | Emphysema (HP:0002097) | 1.98051482 |
| 103 | Diminished motivation (HP:0000745) | 1.97702613 |
| 104 | Axonal loss (HP:0003447) | 1.97313325 |
| 105 | Premature loss of primary teeth (HP:0006323) | 1.96279323 |
| 106 | Epistaxis (HP:0000421) | 1.95884697 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94242544 |
| 108 | Nephritis (HP:0000123) | 1.93339613 |
| 109 | Eosinophilia (HP:0001880) | 1.93264966 |
| 110 | Abnormal platelet function (HP:0011869) | 1.92786288 |
| 111 | Impaired platelet aggregation (HP:0003540) | 1.92786288 |
| 112 | Recurrent pneumonia (HP:0006532) | 1.92682263 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 1.92624031 |
| 114 | Restrictive lung disease (HP:0002091) | 1.92559032 |
| 115 | Agnosia (HP:0010524) | 1.92335928 |
| 116 | Slow saccadic eye movements (HP:0000514) | 1.90382220 |
| 117 | Abnormality of the pericardium (HP:0001697) | 1.88903640 |
| 118 | Apathy (HP:0000741) | 1.88700856 |
| 119 | Viral hepatitis (HP:0006562) | 1.88493007 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.88334579 |
| 121 | Basal ganglia calcification (HP:0002135) | 1.88306391 |
| 122 | Myocardial infarction (HP:0001658) | 1.88247814 |
| 123 | Abnormality of complement system (HP:0005339) | 1.87787548 |
| 124 | Sepsis (HP:0100806) | 1.86612881 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.85772857 |
| 126 | Gingival bleeding (HP:0000225) | 1.85394530 |
| 127 | Amaurosis fugax (HP:0100576) | 1.84658587 |
| 128 | Frequent falls (HP:0002359) | 1.83534706 |
| 129 | Gangrene (HP:0100758) | 1.82441164 |
| 130 | Arthralgia (HP:0002829) | 1.82087310 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81667169 |
| 132 | Skin rash (HP:0000988) | 1.81340493 |
| 133 | Polygenic inheritance (HP:0010982) | 1.80598798 |
| 134 | Upper motor neuron abnormality (HP:0002127) | 1.77715185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.92716739 |
| 2 | BLK | 3.27116476 |
| 3 | TRIB3 | 3.06626337 |
| 4 | PRPF4B | 2.84568422 |
| 5 | ERN1 | 2.82066615 |
| 6 | PKN2 | 2.58003897 |
| 7 | STK10 | 2.46035394 |
| 8 | ZAP70 | 2.34207234 |
| 9 | TYK2 | 2.27187996 |
| 10 | GRK6 | 2.24346601 |
| 11 | TBK1 | 2.19497536 |
| 12 | EEF2K | 2.18010133 |
| 13 | IRAK4 | 2.15283981 |
| 14 | TXK | 2.14358038 |
| 15 | MAP3K10 | 2.11024644 |
| 16 | JAK3 | 1.97070151 |
| 17 | LRRK2 | 1.79461336 |
| 18 | SIK3 | 1.76990348 |
| 19 | TESK2 | 1.73694026 |
| 20 | BTK | 1.72846040 |
| 21 | CSK | 1.69762910 |
| 22 | TGFBR2 | 1.69563315 |
| 23 | RIPK4 | 1.67867558 |
| 24 | MAP3K14 | 1.66566373 |
| 25 | EPHB1 | 1.61489708 |
| 26 | HCK | 1.54509888 |
| 27 | SMG1 | 1.53809596 |
| 28 | KIT | 1.51343251 |
| 29 | CSF1R | 1.48273496 |
| 30 | FES | 1.47255394 |
| 31 | ITK | 1.47035826 |
| 32 | SYK | 1.44365546 |
| 33 | IKBKE | 1.42402022 |
| 34 | TAOK2 | 1.40570653 |
| 35 | PTK6 | 1.35902641 |
| 36 | JAK1 | 1.30734711 |
| 37 | MAP2K3 | 1.23243255 |
| 38 | LCK | 1.22035183 |
| 39 | RPS6KA4 | 1.21796078 |
| 40 | RIPK1 | 1.21529532 |
| 41 | CLK1 | 1.19942814 |
| 42 | SIK2 | 1.19243417 |
| 43 | TESK1 | 1.17041399 |
| 44 | TTN | 1.14018674 |
| 45 | IKBKB | 1.13523633 |
| 46 | MAP3K11 | 1.11993303 |
| 47 | FGFR4 | 1.10812424 |
| 48 | NME2 | 1.04918784 |
| 49 | BMX | 1.03528249 |
| 50 | SCYL2 | 1.02963075 |
| 51 | PAK4 | 1.01986055 |
| 52 | MARK3 | 1.01328050 |
| 53 | FGR | 1.00513600 |
| 54 | TEC | 1.00477953 |
| 55 | PIM1 | 0.99410649 |
| 56 | KDR | 0.97717089 |
| 57 | YES1 | 0.95981060 |
| 58 | PRKD2 | 0.92608945 |
| 59 | CDK12 | 0.92276580 |
| 60 | CAMK1D | 0.92219461 |
| 61 | ALK | 0.91824569 |
| 62 | JAK2 | 0.91801308 |
| 63 | IRAK3 | 0.91399754 |
| 64 | LYN | 0.90275169 |
| 65 | BMPR2 | 0.89816311 |
| 66 | MAP3K13 | 0.89533961 |
| 67 | CDK19 | 0.88310524 |
| 68 | FGFR3 | 0.81674816 |
| 69 | PRKCH | 0.81033424 |
| 70 | MOS | 0.80987629 |
| 71 | CDC42BPA | 0.79203342 |
| 72 | MARK2 | 0.77426094 |
| 73 | IRAK2 | 0.76561599 |
| 74 | PDPK1 | 0.76140089 |
| 75 | CHUK | 0.74701533 |
| 76 | PIM2 | 0.68297343 |
| 77 | TAOK3 | 0.66920102 |
| 78 | MST1R | 0.66886732 |
| 79 | MAP3K8 | 0.66597495 |
| 80 | TAOK1 | 0.62685836 |
| 81 | CAMK1G | 0.62161964 |
| 82 | NEK2 | 0.59831883 |
| 83 | ARAF | 0.59242311 |
| 84 | RPS6KA6 | 0.56768345 |
| 85 | IRAK1 | 0.56672257 |
| 86 | MAP3K6 | 0.54901911 |
| 87 | FLT3 | 0.53132294 |
| 88 | EGFR | 0.51218805 |
| 89 | MATK | 0.50964927 |
| 90 | RPS6KL1 | 0.49439107 |
| 91 | RPS6KC1 | 0.49439107 |
| 92 | KSR1 | 0.49289235 |
| 93 | PTK2B | 0.49147984 |
| 94 | GRK7 | 0.48577054 |
| 95 | MAP3K3 | 0.48245003 |
| 96 | CDK6 | 0.47771949 |
| 97 | MST4 | 0.47706544 |
| 98 | NEK9 | 0.47096301 |
| 99 | CDK4 | 0.46925012 |
| 100 | MAPK7 | 0.45955332 |
| 101 | TRPM7 | 0.45503425 |
| 102 | PRKCQ | 0.45449877 |
| 103 | MAP3K7 | 0.45292300 |
| 104 | MAP3K5 | 0.45242346 |
| 105 | RPS6KA2 | 0.44559846 |
| 106 | MAPKAPK2 | 0.43890129 |
| 107 | FYN | 0.43499536 |
| 108 | HIPK2 | 0.43413402 |
| 109 | MAPK12 | 0.42487940 |
| 110 | TNK2 | 0.41820526 |
| 111 | EPHA3 | 0.41764798 |
| 112 | CAMKK1 | 0.40813710 |
| 113 | DMPK | 0.40650873 |
| 114 | DYRK1B | 0.39700004 |
| 115 | ICK | 0.39639949 |
| 116 | SIK1 | 0.37939404 |
| 117 | RAF1 | 0.37894309 |
| 118 | PRKG2 | 0.37533575 |
| 119 | PDK1 | 0.37267291 |
| 120 | KSR2 | 0.36965234 |
| 121 | STK4 | 0.36741223 |
| 122 | PRKCD | 0.36270193 |
| 123 | ABL1 | 0.35342475 |
| 124 | ILK | 0.34930948 |
| 125 | MAP3K1 | 0.33951740 |
| 126 | RPS6KA1 | 0.32323996 |
| 127 | STK38 | 0.31441322 |
| 128 | PIK3CG | 0.31087426 |
| 129 | MAPK4 | 0.30858166 |
| 130 | CAMKK2 | 0.30675771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.08739579 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86934076 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56688549 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.35970310 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34463202 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22799352 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13657197 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.07724638 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02855741 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99620426 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.93364917 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90695188 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89664584 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.89652895 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.84880543 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.84117152 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77559617 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.76437252 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.75416474 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74032106 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73319291 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67734849 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67243984 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.66429590 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65205286 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58505309 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56735374 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56228576 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.52563763 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46513750 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46036866 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.41150408 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40352397 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.39988946 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36803115 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30687767 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30082581 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29916303 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29882291 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29126708 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.29105425 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.28146505 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.27906307 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26394787 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.25243760 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21794706 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 1.19978069 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19921721 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.14737317 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14525453 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13747584 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.09910467 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01549880 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93119402 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92902096 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89226446 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88850504 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.84477032 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81746119 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.80407843 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.79346864 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79155343 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78954404 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77752079 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76582070 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75481257 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73801829 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72042540 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68916084 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68858567 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67083189 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62650479 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59301109 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58849915 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57398382 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57119557 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56948858 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54843155 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50489678 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50477803 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.49711100 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.49542053 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.49121063 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47699302 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46931241 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44425293 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43488785 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.43348111 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42504575 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41331757 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41278351 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40968785 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40852618 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40803400 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40041039 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.39851794 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39480462 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39234338 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38878882 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37885890 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.36413700 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36256066 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35165427 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33882843 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33471035 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33121231 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.31949667 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31049329 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.29550021 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28696656 |

